...indications for use shall be included in the directions for use of the drug, as required by section 502(f)(l) of the act and by the regulations in this part. (c)...designed to be displayed. [33 FR 9482, June 28, 1968] § 1.102b Drugs and devices in package form; labeling re name and place of business of manufacturer,...

...indications for use shall be Included in the directions for use of the drug, as required by section 502(f)(l) of the act and by the regulations in this part. (c)...package rests as it is designed to be displayed. [ 33 PR 9482. June 28, 1968 1 § 1.1021» Drugs and device« in package form ; labeling re name and place...

...indications for use shall be included in the directions for use of the drug, as required by section 502(f)(l) of the act and by the regulations in this part. (c)...package rests as it is designed to be displayed. [33 PR 9482. June 28, 1968] § 1. 1021. Drugs and devices in package form; labeling re name and place of...

...indications for ose shall be included in the directions for use of the drug, as required by section 502(0(1) of the act and by the regula-tions in this part. (c)...the package rests as it is designed to be displayed. {201.62 Declaration of net quantity of content*. (a) The label of an over-the-counter drug in package...

...indications for use shall be included in the directions for use of the drug, as required by section 502(f)(l) of the act and by the regulations in this part. (c)...matter on such panel, and shall be in lines generally patai\e\ to the base on which the package rests as it is designed to be displayed. $201.62 Declaration...

...vignette representing the intended cosmetic use. (c) The statement of identity shall be presented in bold type on the principal display panel, shall be in a...the package rests as it is designed to be displayed. § 701.12 Name and place of business of manufacturer, packer, or distributor. (a) The label of a cosmetic...

...intended cosmetic use. (c) The statement of identity shall be presented in bold type on the prin cipal display panel, shall be in a size reasonably related...the package rests as it is designed to be displayed. § 701.12 Name and place of business manufacturer, packer, or distributor. (a) The label of a cosmetic...

...section 401 of the act. (d) This statement of identity shall be presented in bold type on the prinnpal display panel, shall be In a size reasonably related...the package rests as it Is designed to be displayed. te> Under the provisions of section 4O3(c) of the Federal Food, Drug, and Cosmetic Act, a food shall...

...presented in bold face type on the principal display panel, shall be in a 21 CFR Gh. l (4-1-89 Edition) size reasonably related to the most prominent printed...the package rests as it is designed to be displayed. §201.62 Declaration of net quantity of contents. (a) The label of an over-the-counter drug In package...

...included in the directions for use of the drug, as required by section 502 (f HI) of the act and by Шл regulations in this part. (c) The statement of identity...is designed to be displayed. [33 FR 9482, June 28, 1966; effective July 1, 1969] § 1.1 02b Drugs and devices in package form; labeling re name and place...